When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Platelet transfusion - Wikipedia

   en.wikipedia.org/wiki/Platelet_transfusion

   Platelet transfusion, is the process of infusing platelet concentrate into the body via vein, to prevent or treat the bleeding in people with either a low platelet count or poor platelet function. [1] Often this occurs in people receiving cancer chemotherapy. [1]

3. Estramustine phosphate - Wikipedia

   en.wikipedia.org/wiki/Estramustine_phosphate

   However, encouraging clinical research findings resulted in renewed interest of EMP for the treatment of prostate cancer. [3] EMP has been used at doses of 140 to 1,400 mg/day orally in the treatment of prostate cancer. [19] However, oral EMP is most commonly used at a dose of 560 to 640 mg/day (280–320 mg twice daily). [1]

4. Management of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Management_of_prostate_cancer

   For men over 64 with prostate cancer limited to the pelvis, using fewer, larger doses of radiation (hypofractionation) results in similar overall survival rates. [28] The risk of dying from prostate cancer or having acute bladder side effects may be similar to that of longer radiation treatment. [28]

5. Plateletpheresis - Wikipedia

   en.wikipedia.org/wiki/Plateletpheresis

   In a typical set of rules, a platelet donor must weigh at least 50 kg (110 lb) and have a platelet count of at least 150 x 10 9 /L (150,000 platelets per mm³). [2] One unit has greater than 3×10 11 platelets. Therefore, it takes 2 liters of blood having a platelet count of 150,000/mm³ to produce one unit of platelets.

6. Thrombocytopenia - Wikipedia

   en.wikipedia.org/wiki/Thrombocytopenia

   One common definition of thrombocytopenia requiring emergency treatment is a platelet count below 50,000/μL. [5] Thrombocytopenia can be contrasted with the conditions associated with an abnormally high level of platelets in the blood – thrombocythemia (when the cause is unknown), and thrombocytosis (when the cause is known). [6] [7]

7. Cancer immunotherapy - Wikipedia

   en.wikipedia.org/wiki/Cancer_immunotherapy

   The most common side effects when used with other cancer medicines include peripheral neuropathy (nerve damage in the hands and feet), nausea, anemia (low red blood cell counts), neutropenia (low white blood cell counts), thrombocytopenia (low platelet counts), rash, tiredness, constipation, reduced appetite, diarrhea, and cough. [76]